Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

BIZARRE: Is boston scientific stock outperforming the s p 500 - What They Never Told You

Based in Marlborough, Massachusetts, Boston Scientific Corporation (BSX) operates in the medical device industry with a market cap of $113.1 billion. The company develops, manufactures, and markets innovative devices for cardiovascular, rhythm and neuro, and MedSurg applications, addressing a wide range of interventional medical needs worldwide.

Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Boston Scientific fits this criterion perfectly, exceeding the mark. Boston Scientific's groundbreaking medical devices, particularly the Taxus drug-eluting stents and the EMBLEM subcutaneous implantable defibrillator (S-ICD), fuel its significant revenue streams and solidify its dominant position in the global medical technology market.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.